AG Encourages Appeal Of Death Penalty Drug Return

By: Office of the Nebraska Attorney General
By: Office of the Nebraska Attorney General

Attorney General Jon Bruning today released a statement on the state's response to the Food and Drug Administration (FDA) regarding sodium thiopental. In the response letter sent today, Nebraska encouraged the federal agency to appeal the order in the case of Beaty v Federal Drug Administration.

"The FDA should appeal the Court's decision," said Bruning. "Nebraska's supply of sodium thiopental was purchased from a different supplier and was approved for importation by the U.S. DEA, FDA and Customs."

U.S. District Judge Richard Leon's court order does not apply to Nebraska and has no bearing on the sodium thiopental in the possession of Nebraska Department of Correctional Services. The supply referenced in the Washington, D.C. Beaty case was purchased from Dream Pharma and previously was detained by the FDA as an unapproved and misbranded drug.

Nebraska's letter states the Court's order was clearly wrong and contrary to the 1985 United States Supreme Court decision in Heckler v Cheney which gave complete authority to the Secretary of Health and Human Services "to decide how and when" to enforce provisions of the federal FDA Act.

KOLN-TV Call: (402) 467-4321 Toll-free: 1-800-475-1011 840 North 40th Lincoln, NE 68503 Email: KGIN-TV Call: (308) 382-6100 123 N Locust Street Grand Island, NE 68802 Email: KSNB-TV Toll free 888-475-1011 123 N. Locust St. Grand Island, NE 68802 Email :
Copyright © 2002-2015 - Designed by Gray Digital Media - Powered by Clickability 148275125 -
Gray Television, Inc.